According to FutureWise analysis the market for anti epilepsy drugs in 2023 is US$ 18.08 billion, and is expected to reach US$ 25.75 billion by 2031 at a CAGR of 4.5%.
Epilepsy is a neurological condition that disrupts brain function through frequent seizures. Seizures are bursts of electrical activity within the brain that temporarily affect cognitive and physical functions. Antiepileptic drugs are those which decrease the severity or frequency of seizures in people with epilepsy. Epilepsy can start at any age but usually initiates in childhood or individuals aged 60 and above. It's often a lifelong condition, but it can sometimes get slowly better over time. The selection of an appropriate anti-epilepsy drug depends on factors such as the type of seizures, the individual's age, any potential side effects, and medical history. Individuals with epilepsy must work closely with a healthcare expert to find the most effective and suitable medication regimen.
An antiepileptic medication is swallowed orally and passes directly to the stomach. Once absorbed into the bloodstream from the stomach, the medication travels through the liver and subsequently targets nerve cells within the brain. During its circulation in the bloodstream, the drug undergoes elimination through metabolic breakdown by the liver or excretion through the kidneys. Certain drug metabolites are active and produce either beneficial antiepileptic or undesired side effects. Most commonly prescribed antiepileptic medications are released from the blood at a rate that permits twice-daily dosing to maintain blood levels. Some drugs are removed quickly than others and have to be taken three or four times daily, while others are removed slowly and can be taken once daily.
FutureWise Market Research has published a report that provides an insightful analysis anti epilepsy drugs market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, anti epilepsy drugs market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.